Combination MET inhibition and Topoisomerase I inhibition block cell growth of Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a devastating disease, and current therapies have not greatly improved the 5-year survival rates. Topoisomerase (Top) inhibition is a treatment modality for SCLC; however, the response is short lived. Consequently, our research has focused on improving SCLC therapeut...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Mol Cancer Ther
Główni autorzy: Rolle, Cleo E., Kanteti, Rajani, Surati, Mosmi, Nandi, Suvobroto, Dhanasingh, Immanuel, Yala, Soheil, Tretiakova, Maria, Arif, Qudsia, Hembrough, Todd, Brand, Toni M., Wheeler, Deric L., Husain, Aliya N., Vokes, Everett E., Bharti, Ajit, Salgia, Ravi
Format: Artigo
Język:Inglês
Wydane: 2013
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286701/
https://ncbi.nlm.nih.gov/pubmed/24327519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0109
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy